295 related articles for article (PubMed ID: 26814015)
1. Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity.
Patterson RE; Kalavalapalli S; Williams CM; Nautiyal M; Mathew JT; Martinez J; Reinhard MK; McDougall DJ; Rocca JR; Yost RA; Cusi K; Garrett TJ; Sunny NE
Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E484-94. PubMed ID: 26814015
[TBL] [Abstract][Full Text] [Related]
2. Impact of exenatide on mitochondrial lipid metabolism in mice with nonalcoholic steatohepatitis.
Kalavalapalli S; Bril F; Guingab J; Vergara A; Garrett TJ; Sunny NE; Cusi K
J Endocrinol; 2019 Jun; 241(3):293-305. PubMed ID: 31082799
[TBL] [Abstract][Full Text] [Related]
3. Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease.
Sunny NE; Kalavalapalli S; Bril F; Garrett TJ; Nautiyal M; Mathew JT; Williams CM; Cusi K
Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E311-9. PubMed ID: 26058864
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone improves hepatic mitochondrial function in a mouse model of nonalcoholic steatohepatitis.
Kalavalapalli S; Bril F; Koelmel JP; Abdo K; Guingab J; Andrews P; Li WY; Jose D; Yost RA; Frye RF; Garrett TJ; Cusi K; Sunny NE
Am J Physiol Endocrinol Metab; 2018 Aug; 315(2):E163-E173. PubMed ID: 29634314
[TBL] [Abstract][Full Text] [Related]
5. Aerobic capacity and hepatic mitochondrial lipid oxidation alters susceptibility for chronic high-fat diet-induced hepatic steatosis.
Morris EM; Meers GM; Koch LG; Britton SL; Fletcher JA; Fu X; Shankar K; Burgess SC; Ibdah JA; Rector RS; Thyfault JP
Am J Physiol Endocrinol Metab; 2016 Oct; 311(4):E749-E760. PubMed ID: 27600823
[TBL] [Abstract][Full Text] [Related]
6. A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition.
Krishnan A; Abdullah TS; Mounajjed T; Hartono S; McConico A; White T; LeBrasseur N; Lanza I; Nair S; Gores G; Charlton M
Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G666-G680. PubMed ID: 28232454
[TBL] [Abstract][Full Text] [Related]
7. Hepatic ketogenic insufficiency reprograms hepatic glycogen metabolism and the lipidome.
d'Avignon DA; Puchalska P; Ercal B; Chang Y; Martin SE; Graham MJ; Patti GJ; Han X; Crawford PA
JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925686
[TBL] [Abstract][Full Text] [Related]
8. Branched chain amino acids and carbohydrate restriction exacerbate ketogenesis and hepatic mitochondrial oxidative dysfunction during NAFLD.
Muyyarikkandy MS; McLeod M; Maguire M; Mahar R; Kattapuram N; Zhang C; Surugihalli C; Muralidaran V; Vavilikolanu K; Mathews CE; Merritt ME; Sunny NE
FASEB J; 2020 Nov; 34(11):14832-14849. PubMed ID: 32918763
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Pyruvate Dehydrogenase Kinase 2 Protects Against Hepatic Steatosis Through Modulation of Tricarboxylic Acid Cycle Anaplerosis and Ketogenesis.
Go Y; Jeong JY; Jeoung NH; Jeon JH; Park BY; Kang HJ; Ha CM; Choi YK; Lee SJ; Ham HJ; Kim BG; Park KG; Park SY; Lee CH; Choi CS; Park TS; Lee WN; Harris RA; Lee IK
Diabetes; 2016 Oct; 65(10):2876-87. PubMed ID: 27385159
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance is mechanistically linked to hepatic mitochondrial remodeling in non-alcoholic fatty liver disease.
Shannon CE; Ragavan M; Palavicini JP; Fourcaudot M; Bakewell TM; Valdez IA; Ayala I; Jin ES; Madesh M; Han X; Merritt ME; Norton L
Mol Metab; 2021 Mar; 45():101154. PubMed ID: 33359401
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction.
Boland ML; Oldham S; Boland BB; Will S; Lapointe JM; Guionaud S; Rhodes CJ; Trevaskis JL
World J Gastroenterol; 2018 Apr; 24(16):1748-1765. PubMed ID: 29713129
[TBL] [Abstract][Full Text] [Related]
12. Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver.
Satapati S; Sunny NE; Kucejova B; Fu X; He TT; Méndez-Lucas A; Shelton JM; Perales JC; Browning JD; Burgess SC
J Lipid Res; 2012 Jun; 53(6):1080-92. PubMed ID: 22493093
[TBL] [Abstract][Full Text] [Related]
13. Thyroid Hormone Decreases Hepatic Steatosis, Inflammation, and Fibrosis in a Dietary Mouse Model of Nonalcoholic Steatohepatitis.
Zhou J; Tripathi M; Ho JP; Widjaja AA; Shekeran SG; Camat MD; James A; Wu Y; Ching J; Kovalik JP; Lim KH; Cook SA; Bay BH; Singh BK; Yen PM
Thyroid; 2022 Jun; 32(6):725-738. PubMed ID: 35317606
[No Abstract] [Full Text] [Related]
14. Prevention of free fatty acid-induced hepatic lipotoxicity by carnitine via reversal of mitochondrial dysfunction.
Jun DW; Cho WK; Jun JH; Kwon HJ; Jang KS; Kim HJ; Jeon HJ; Lee KN; Lee HL; Lee OY; Yoon BC; Choi HS; Hahm JS; Lee MH
Liver Int; 2011 Oct; 31(9):1315-24. PubMed ID: 22093454
[TBL] [Abstract][Full Text] [Related]
15. Hepatic Mitochondrial Oxidative Metabolism and Lipogenesis Synergistically Adapt to Mediate Healthy Embryonic-to-Neonatal Transition in Chicken.
Surugihalli C; Porter TE; Chan A; Farley LS; Maguire M; Zhang C; Kattapuram N; Muyyarikkandy MS; Liu HC; Sunny NE
Sci Rep; 2019 Dec; 9(1):20167. PubMed ID: 31882889
[TBL] [Abstract][Full Text] [Related]
16. Alterations of hepatic energy metabolism in murine models of obesity, diabetes and fatty liver diseases.
Dewidar B; Mastrototaro L; Englisch C; Ress C; Granata C; Rohbeck E; Pesta D; Heilmann G; Wolkersdorfer M; Esposito I; Reina Do Fundo M; Zivehe F; Yavas A; Roden M
EBioMedicine; 2023 Aug; 94():104714. PubMed ID: 37454552
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a murine nonalcoholic steatohepatitis model induced by high fat high calorie diet plus fructose and glucose in drinking water.
Liu XJ; Duan NN; Liu C; Niu C; Liu XP; Wu J
Lab Invest; 2018 Sep; 98(9):1184-1199. PubMed ID: 29959418
[TBL] [Abstract][Full Text] [Related]
18. Liraglutide improves hepatic steatosis and metabolic dysfunctions in a 3-week dietary mouse model of nonalcoholic steatohepatitis.
Duparc T; Briand F; Trenteseaux C; Merian J; Combes G; Najib S; Sulpice T; Martinez LO
Am J Physiol Gastrointest Liver Physiol; 2019 Oct; 317(4):G508-G517. PubMed ID: 31460789
[TBL] [Abstract][Full Text] [Related]
19. High fat diet feeding results in gender specific steatohepatitis and inflammasome activation.
Ganz M; Csak T; Szabo G
World J Gastroenterol; 2014 Jul; 20(26):8525-34. PubMed ID: 25024607
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice.
Yamamoto T; Nakade Y; Yamauchi T; Kobayashi Y; Ishii N; Ohashi T; Ito K; Sato K; Fukuzawa Y; Yoneda M
World J Gastroenterol; 2016 Feb; 22(8):2512-23. PubMed ID: 26937139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
